Dan Moore

President & Chief Executive Officer
Cyberonics, Inc.

Dan Moore became president and chief executive officer of Cyberonics in 2007. Under his direction, Cyberonics has focused on its core expertise in neuromodulation, other medical devices for epilepsy and expanding the Vagus Nerve Stimulation (VNS) Therapy franchise, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. He has spearheaded strategic investments in growth areas beyond epilepsy, including chronic heart failure and obstructive sleep apnea. Most recently, Moore orchestrated the $3 billion dollar merger of Cyberonics with Sorin, which will create a global medical device company with significant capabilities in areas ranging from cardiac surgery and epilepsy to heart failure and sleep apnea.